UK MHRA Approves Adapted Pfizer/BioNTech Covid-19 Vaccine Targeting KP.2 Subvariant for Adults

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved an adapted version of the Pfizer/BioNTech Covid-19 vaccine, known as Comirnaty. This updated vaccine specifically targets the KP.2 Covid-19 subvariant and is intended for use in adults.